Patents by Inventor Revital Lifshitz-Liron

Revital Lifshitz-Liron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090018182
    Abstract: Novel forms of atorvastatin hemi-calcium have been prepared and characterized. These novel forms are particularly useful in pharmaceutical compositions.
    Type: Application
    Filed: June 28, 2007
    Publication date: January 15, 2009
    Inventors: Sigalit Levi, Revital Lifshitz-Liron, Sharon Avhar-Maydan
  • Publication number: 20090012047
    Abstract: Provided are crystalline forms of ibandronate sodium, as well as processes for the preparation thereof.
    Type: Application
    Filed: November 16, 2007
    Publication date: January 8, 2009
    Inventors: Eran Turgeman, Revital Lifshitz-Liron, Claude Singer, Tamas Koltai
  • Patent number: 7456297
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: November 25, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Limor Tessler, Judith Aronhime, Revital Lifshitz-Liron, Dalia Maidan-Hanoch, Nir Hasson
  • Patent number: 7449603
    Abstract: Provided is a process for preparing Cinacalcet, (R)-?-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine and intermediates thereof.
    Type: Grant
    Filed: April 27, 2007
    Date of Patent: November 11, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventor: Revital Lifshitz-Liron
  • Patent number: 7435827
    Abstract: The invention relates to polymorphs of zoledronic acid and zoledronate sodium salts, amorphous zoledronate sodium salt, processes for making the polymorphs and amorphous zoledronate sodium salt, and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt.
    Type: Grant
    Filed: September 25, 2006
    Date of Patent: October 14, 2008
    Assignee: Teva Pharmaceutical Industries Ltd
    Inventors: Judith Aronhime, Revital Lifshitz-Liron
  • Publication number: 20080200532
    Abstract: Provided are polymorphic forms of fluvastatin sodium and processes for their preparation.
    Type: Application
    Filed: April 23, 2008
    Publication date: August 21, 2008
    Inventors: Revital Lifshitz-Liron, Tamas Koltai, Judith Aronhime, Nurit Perlman
  • Patent number: 7414140
    Abstract: Provided are polymorphic forms of fluvastatin sodium and processes for their preparation.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: August 19, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Revital Lifshitz-Liron, Tamas Koltai, Judith Aronhime, Nurit Perlman, Sharon Avhar-Maydan
  • Patent number: 7393967
    Abstract: Provided is a process for preparing cinacalcet, (R)-?-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine.
    Type: Grant
    Filed: April 27, 2007
    Date of Patent: July 1, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventor: Revital Lifshitz-Liron
  • Publication number: 20080146817
    Abstract: Provided are crystalline forms of fluvastatin sodium and processes for their preparation.
    Type: Application
    Filed: January 29, 2007
    Publication date: June 19, 2008
    Inventors: Revital Lifshitz-Liron, Tamas Koltai, Judith Aronhime, Nurit Perlman, Sharon Avhar-Maydan
  • Patent number: 7368468
    Abstract: Provided are polymorphic forms of fluvastatin sodium and processes for their preparation.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: May 6, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Revital Lifshitz-Liron, Tamas Koltai, Judith Aronhime, Nurit Perlman
  • Patent number: 7368606
    Abstract: Provided is amorphous cinacalcet hydrochloride, processes for the preparation thereof, and pharmaceutical compositions therewith.
    Type: Grant
    Filed: May 23, 2006
    Date of Patent: May 6, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Revital Lifshitz-Liron, Michael Pinchasov, Shlomit Wizel, Sharon Avhar-Maydan
  • Patent number: 7358360
    Abstract: The present invention relates to a method of making risedronate sodium substantially free of iron including the steps of refluxing, especially with mechanical agitation, a combination of risedronic acid, a sodium base, especially sodium hydroxide, and an iron-reducing amount of EDTA in a liquid that is water, a lower alkanol, or, especially, a mixture of a lower alkanol and water; and isolating risedronate sodium substantially free of iron from the combination.
    Type: Grant
    Filed: January 16, 2004
    Date of Patent: April 15, 2008
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Revital Lifshitz-Liron, Ramiy Lidor-Hadas, Nissm Sasson, Igor Lifshitz
  • Publication number: 20080009466
    Abstract: The invention relates to solid crystalline forms of ibandronic acid, pharmaceutical formulations thereof, and methods of treatment therewith.
    Type: Application
    Filed: April 25, 2007
    Publication date: January 10, 2008
    Inventors: Sharon Avhar-Maydan, Eyal Gilboa, Tamas Koltai, Revital Lifshitz-Liron
  • Publication number: 20070265456
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin. Also provided is atorvastatin hemi-calcium Form VIII that is stable against the formation of atorvastatin hemi-calcium is atorvastatin calcium epoxy dihydroxy (AED).
    Type: Application
    Filed: May 9, 2006
    Publication date: November 15, 2007
    Inventors: Judith Aronhime, Ramy Lidor-Hadas, Valerie Niddam-Hildesheim, Shlomit Wizel, Revital Lifshitz-Liron, Michael Pinchasov
  • Patent number: 7294735
    Abstract: Isolated cinacalcet carbamate, processes for the preparation thereof, and processes for the use of cinacalcet carbamate as a reference marker and standard are provided. Also provided are cinacalcet salts substantially free of cinacalcet carbamate, and processes for the preparation thereof.
    Type: Grant
    Filed: May 23, 2006
    Date of Patent: November 13, 2007
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Revital Lifshitz-Liron, Yuriy Raizi, Revital Ramaty, Esti Marom
  • Publication number: 20070259964
    Abstract: Provided is a process for preparing Cinacalcet, (R)-?-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine and intermediates thereof.
    Type: Application
    Filed: April 27, 2007
    Publication date: November 8, 2007
    Inventor: Revital Lifshitz-Liron
  • Publication number: 20070260091
    Abstract: Provided is a process for preparing cinacalcet, (R)-?-methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethane amine.
    Type: Application
    Filed: April 27, 2007
    Publication date: November 8, 2007
    Inventor: Revital Lifshitz-Liron
  • Patent number: 7256212
    Abstract: The present invention provides novel forms of atorvastatin designated Forms VI, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II, IV, V and amorphous atorvastatin.
    Type: Grant
    Filed: July 29, 2005
    Date of Patent: August 14, 2007
    Assignee: Teva Pharmaceutical Industries Ltd.
    Inventors: Limor Tessler, Judith Aronhime, Revital Lifshitz-Liron, Dalia Maidan-Hanoch, Nir Hasson
  • Publication number: 20070185211
    Abstract: Provided are crystalline forms of cinacalcet HCl and processes for their preparation.
    Type: Application
    Filed: November 22, 2006
    Publication date: August 9, 2007
    Inventors: Shlomit Wizel, Revital Lifshitz-Liron, Sharon Avhar-Maydan
  • Publication number: 20070179119
    Abstract: The present invention relates to solid amorphous and crystalline forms of ibandronate sodium.
    Type: Application
    Filed: December 22, 2006
    Publication date: August 2, 2007
    Inventors: Revital Lifshitz-Liron, Thomas Bayer, Judith Aronhime, Michael Pinchasov